SCHEMBL7607496

SCHEMBL7607496

NNC(=O)c1c(F)c(F)c(F)c(F)c1F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.56
PKM P14618 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
MAPK1 P28482 1/20 0.46
TSHR P16473 2/20 0.45
RECQL P46063 1/20 0.45
GAA P10253 1/20 0.45
HSD17B10 Q99714 1/20 0.42
CA1 P00915 4/20 0.42
CA2 P00918 4/20 0.42
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
TAS1R2 Q8TE23 1/20 0.41
HDAC3 O15379 2/20 0.40
HDAC8 Q9BY41 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
HDAC11 Q96DB2 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8570432 0.94 HTT (0.50) HTTPKMSMN1; SMN2LMNATP53
SCHEMBL9425021 0.80 CA1 (0.52) HTTLMNARECQLGAACA1
SCHEMBL28723691 0.78 KDM4E (0.44) HTTSMN1; SMN2LMNATSHRRECQL
SCHEMBL7600517 0.77 HTT (0.41) HTTPKMSMN1; SMN2LMNATP53
SCHEMBL13623386 0.77 HTT (0.54) HTTPKMSMN1; SMN2LMNATP53
SCHEMBL2354218 0.77 HTT (0.54) HTTPKMSMN1; SMN2LMNATP53
SCHEMBL14172477 0.76 HTT (0.36) HTTPKMSMN1; SMN2LMNATP53
SCHEMBL24687425 0.76 HTT (0.67) HTTPKMSMN1; SMN2LMNATP53
SCHEMBL28623178 0.74 HDAC6 (0.55) HTTPKMSMN1; SMN2LMNATP53
SCHEMBL8472464 0.74 HTT (0.52) HTTPKMSMN1; SMN2LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107531857-B Thermally reactive composition 株式会社艾迪科 2021-06-18 CN disclosed
US-20020198254-A1 Polyamide analogs GENELABS TECHNOLOGIES, INC. 2002-12-26 US disclosed
WO-2002062755-A2 POLYAMIDE ANALOGS AS DNA MINOR GROOVE BINDERS GENELABS TECHNOLOGIES, INC. (US) 2002-08-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020198254-A1 Polyamide analogs CYP51A1, HDAC6, ERG28 HTT 2541/4885PKM 1316/4885SMN1; SMN2 862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.